Scientists at Israel’s Weizmann Institute have made a breakthrough in treating triple negative breast cancer. This cancer lacks three receptors that serve as targets for anti-cancer drugs. However, inhibiting molecules EGFR and PYK2 significantly reduces the size of tumors.
Dual action treatment for aggressive breast cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.